Differentiation of the formulation would imply longer periods for registration in the exporting and in the importing country, since proof of bioequivalence is dependent on substantial similarity in formulation and dosage.
Differentiation of the formulation would imply longer periods for registration in the exporting and in the importing country, since proof of bioequivalence is dependent on substantial similarity in formulation and dosage.